News | Breast Density | May 22, 2019

VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification

Paper confirms adding volumetric and visual mammographic density improves risk stratification

VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification

May 22, 2019 — Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast Cancer Risk Evaluation Tool improves breast cancer risk stratification. The research suggests VolparaDensity could be used to help guide personalized medicine through risk-adapted screening.

The study, "A case-control study to add volumetric or clinical mammographic density into the Tyrer-Cuzick breast cancer risk model," was published in the May 11 issue of Journal of Breast Imaging, the official journal of the Society of Breast Imaging.

The paper used visual BI-RADS (Breast Imaging-Reporting and Data System) 4th Edition assessments from breast imaging specialists at the University of Virginia (UVA). It included 474 women who were diagnosed with invasive breast cancer alongside 2,243 controls. The results demonstrated that the addition of volumetric and visual mammographic density measures to classical risk factors improves risk stratification, increasing the number of women accurately identified at high and lower risk of breast cancer.  The Tyrer-Cuzick Tool, one of the most complete and widely used risk models, now accepts VolparaDensity volumetric breast density assessment as a validated breast density input in Version 8.

Based on the study results, researchers concluded that risk could be used to guide precision medicine through risk-adapted screening and prevention strategies. Further, they noted in the discussion that "volumetric breast density assessment has some practical advantages because it is fully automated and has excellent agreement with 3-D breast MRI [magnetic resonance imaging]."

Jack Cuzick, Ph.D., John Snow Professor of Epidemiology, director, Wolfson Institute of Preventive Medicine, and head, Centre for Cancer Prevention, stated, "Including breast density into risk models makes sense. Breast density is a strong risk factor for breast cancer, and it is largely independent of all other known risk factors. Breast density contributes as much information as all other factors combined, nearly doubling the predictive value of the risk model. Screening programs need to take this into consideration in order to develop a personalized breast care plan for each woman."

Eric J. Kraemer, M.D., radiologist at Reno Diagnostic Centers, stated, "Incorporating an objective density measure and the Tyrer-Cuzick risk model has allowed us to better personalize screening for all of our patients. Patients with a lifetime risk of greater than 20 percent are recommended for mammography and MRI screening. The personalized plan for patients with dense breasts but with lower risk includes mammography and automated breast ultrasound (ABUS). For patients that do not have dense breasts and that are at low risk of developing breast cancer, mammography continues to be the gold standard in breast cancer screening. Developing a personalized breast care for each woman depending on her specific risk factors means that we can do a better job at detecting cancer earlier, ensuring that lives are saved."

As one of the clinical applications within VolparaEnterprise, the VolparaDensity clinical application provides radiologists with automated, objective volumetric breast density assessments and a breast density category shown to correlate to BI-RADS 4th and 5th Editions. It is CE-marked and cleared by the U.S. Food and Drug Administration (FDA), Health Canada and the TGA.

For more information: www.volparasolutions.com

Reference

1. Brentnall A.R., Cohn W.F., Knaus W.A., et al. A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model. Journal of Breast Imaging, May 11, 2019. doi.org/10.1093/jbi/wbz006

Related Content

Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius 3D Mammography exam
News | Breast Imaging | December 02, 2020
December 2, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s hea
Lunit’s algorithm showed the best performance compared to other commercialized AI algorithms, ultimately reducing the workload of radiologists to classify mammography screenings
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Recent studies have shown that Lunit’s AI solution is as accurate as average radiologists when it
 The study "Will We Solve Crimes with Radiomics? Results of an Experimental Study on Charred Human Bone Samples," was presented at the Virtual Radiological Society of North America's 2020 conference (RSNA20). Radiomics, which extracts data from clinical images, can be reliably used to assess changes in the bone structure due to fire exposure.
News | Computed Tomography (CT) | December 01, 2020
December 1, 2020 — The study "Will We Solve Crimes with Radiomics?
Mary C. Mahoney, M.D.

Mary C. Mahoney, M.D.

News | RSNA | December 01, 2020
December 1, 2020 — At the Virtual RSNA 2020 conference, it was a
Researchers developed a deep learning model that identifies imaging biomarkers to predict a patient’s risk for developing breast cancer

A deep learning model was developed that combined imaging and traditional risk factors.

News | Mammography | November 30, 2020
November 30, 2020 — Researchers at Massachusetts General Hospi...
Chest CT images in a 34-year-old man with fever for 4 days. Positive result of reverse-transcription polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 using a swab sample was obtained on February 8, 2020. Dates of examination are shown on images. A, Chest CT scan with magnification of lesions in coronal and sagittal planes shows a nodule with reversed halo sign in left lower lobe (box) at the early stage of the pneumonia. B, Chest CT scans in different axial planes and coro

Chest CT images in a 34-year-old man with fever for 4 days. Positive result of reverse-transcription polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 using a swab sample was obtained on February 8, 2020. Dates of examination are shown on images. A, Chest CT scan with magnification of lesions in coronal and sagittal planes shows a nodule with reversed halo sign in left lower lobe (box) at the early stage of the pneumonia. B, Chest CT scans in different axial planes and coronal reconstruction show bilateral multifocal ground-glass opacities. The nodular opacity resolved.

News | Coronavirus (COVID-19) | November 29, 2020
November 29, 2020 — The Radiological Society of North America (...
 Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions for chest X-ray and mammography at partner booths.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Lunit, a leading medical AI software company, will be joining the 106th...
ProFound AI for DBT offers superior clinical performance when compared to other commercially available breast AI systems
News | Breast Imaging | November 24, 2020
November 24, 2020 — iCAD reported that over 1,000 licenses have been sold as part of...
Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
News | Mammography | November 20, 2020
November 20, 2020 — Densitas Inc., a global provider of A.I.
Radiologists around the world will have access to a first-of-its-kind online breast density training tool designed to improve radiologists' ability to correctly identify women's breast density categories to comply with the Breast Imaging-Reporting and Data System (BI-RADS), thanks to a collaboration between DetectED-X and Volpara Health. 
News | Breast Density | November 19, 2020
November 19, 2020 — Radiologists around the world will have access to a first-of-its-kind online...